Tamas A. Gonda, MD

As a doctor, I value the privilege to get to know my patients, develop a relationship based on trust, and to make them feel better. In addition to treating illness, prevention of disease, especially prevention of cancer, is my goal and passion both in clinical practice and research.

I specialize in gastroenterology and see people who have diseases of the pancreas or the bile duct, ranging from benign conditions to cancer, and also treat precancerous and malignant diseases of the esophagus, stomach, and colon. At NYU Langone’s Tisch Hospital, I serve as chief of endoscopy and director of the Pancreatic Disease Program.

I am experienced in advanced endoscopy techniques and procedures that are used to manage a range of diseases in the upper and lower esophageal tract. This includes the early detection of precancerous lesions, endoscopic removal of tumors, and treatment of malignant diseases. Pancreatic diseases such as pancreatitis, pancreatic cystic lesions, and pancreatic cancer are a focus of my clinical practice.

I am particularly experienced in the management of complex pancreatic and bile duct diseases, such as acute and chronic pancreatitis and bile duct obstruction. One of my goals is to be able to offer patients treatments with minimal intervention or disruption to their life. Recent innovations in the use of thermal ablation and radiofrequency ablation to shrink tumors without their need for removal is an area of great promise and interest.

At NYU Langone, I am part of a multidisciplinary team that integrates gastroenterology and therapeutic endoscopy with surgery, radiology, oncology, and other medical specialties to provide the best treatment options and high-quality care to patients. I strongly believe that providing a balanced and detailed view of the risks and benefits of each treatment option is critical in patient care.

I present patients with data and recommendations from our team to guide them through the decision-making process, so we can together select the best approach. The Pancreatic Disease Program is one such example where we strive to deliver integrated, multidisciplinary care to our patients in collaboration with the Pancreatic Cancer Center at Perlmutter Cancer Center.

My research focuses on the biology, diagnosis, and treatment of pancreatic and bile duct diseases, including cancer. I am working to detect biomarkers to advance our understanding of the biology of precancerous conditions. This could help to improve diagnoses and identify different levels of risk for developing cancer. I also engage in research on endoscopic therapy for pancreatic cancer and the genetic changes that cause pancreatic and gastrointestinal cancer.

I have published more than 100 peer-reviewed articles in top-tier medical publications and authored text book chapters. My work has been funded by multiple national societies and the National Institutes of Health. I am a fellow of the American Gastroenterological Association and American Society for Gastrointestinal Endoscopy. I received the Landon Foundation–American Association for Cancer Research INNOVATOR Award for Cancer Prevention Research in 2014.